Myasthenia gravis activities of daily living profile

August 30,2024

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial - The Lancet Neurology

JCM, Free Full-Text

A Changing Treatment Landscape in Myasthenia Gravis

Examining the Impact of Refractory Myasthenia Gravis on Healthcare Resource Utilization in the United States: Analysis of a Myasthenia Gravis Foundation of America Patient Registry Sample

Your Guide to Myasthenia Gravis Symptom–Tracking Tools

Understanding the burden of refractory myasthenia gravis - Christiane Schneider-Gold, Tim Hagenacker, Nico Melzer, Tobias Ruck, 2019

Navigating the Disability Insurance Maze - Conquer Myasthenia Gravis

Patient

The Correlation Between Static Fatigue Testing and the Quantitative Myasthenia Gravis Score and Activities of Daily Living Profile

Utilization of MG‐ADL in myasthenia gravis clinical research and care - Muppidi - 2022 - Muscle & Nerve - Wiley Online Library

Frontiers Efficacy and Safety of Immunotherapies in Refractory Myasthenia Gravis: A Systematic Review and Meta-Analysis